Cognition Therapeutics Inc (CGTX) is lower by 9.82% Friday In Premarket Trading

Cognition Therapeutics Inc (CGTX) is lower by Friday morning, with the stock decreasing -9.82% in pre-market trading to 1.01. CGTX's short-term technical score of 20 indicates that the stock has traded less bullishly over the last month than 80% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, Cognition Therapeutics Inc ranks higher than 35% of stocks. Cognition Therapeutics Inc has fallen 13.18% over the past month, closing at $1.44 on September 29. During this period of time, the stock fell as low as $1.12 and as high as $1.50. CGTX has an average analyst recommendation of Strong Buy. The company has an average price target of $6.25.

CGTX has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on CGTX!

See Full CGTX Report

Cognition Therapeutics Inc has a Long-Term Technical rank of 15. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 85% of the market scoring higher. In the Biotechnology industry which is number 131 by this metric, CGTX ranks better than 131% of stocks.

Important Dates for Investors in CGTX:

-Cognition Therapeutics Inc is set to release earnings on 2023-11-13. Over the last 12 months, the company has reported EPS of $-0.86. -We do not have a set dividend date for Cognition Therapeutics Inc at this time. Click Here To Get The Full Report on Cognition Therapeutics Inc (CGTX)